This company seems to have been delisted
Reason: Acquired by Centene
Source: https://investors.centene.com/news-events/press-releases/detail/1011/centene-completes-acquisition-of-magellan-health
Reason: Acquired by Centene
Source: https://investors.centene.com/news-events/press-releases/detail/1011/centene-completes-acquisition-of-magellan-health
Magellan Health
MGLN
₹8,148
Share price
0.00%
Change (1 day)
3.40%
Change (1 year)
Revenue for Magellan Health (MGLN)
Revenue in 2021 (TTM): ₹355.61 Billion
According to Magellan Health 's latest financial reports the company's current revenue is ₹413.56 Billion. In 2020 the company made a revenue of ₹450.27 Billion a decrease over the revenue in the year 2019 that were of ₹614.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Magellan Health from 2001 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | ₹355.61 B | -21.02% |
| 2020 | ₹450.27 B | -26.68% |
| 2019 | ₹614.09 B | -2.12% |
| 2018 | ₹627.37 B | 25.27% |
| 2017 | ₹500.80 B | 20.71% |
| 2016 | ₹414.88 B | 5.21% |
| 2015 | ₹394.34 B | 22.27% |
| 2014 | ₹322.52 B | 6.03% |
| 2013 | ₹304.18 B | 10.57% |
| 2012 | ₹275.11 B | 14.57% |
| 2011 | ₹240.11 B | -5.72% |
| 2010 | ₹254.68 B | 12.39% |
| 2009 | ₹226.60 B | 0.63% |
| 2008 | ₹225.19 B | 21.77% |
| 2007 | ₹184.92 B | 27.55% |
| 2006 | ₹144.98 B | -6.51% |
| 2005 | ₹155.08 B | 0.7% |
| 2004 | ₹154.00 B | 18.84% |
| 2003 | ₹129.58 B | |
| 2001 | ₹150.48 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 TTEC TTEC | ₹185.71 B | -55.09% | 🇺🇸 USA |
 QuinStreet
QNST | ₹88.34 B | -78.64% | 🇺🇸 USA |
 CoStar Group CSGP | ₹241.19 B | -41.68% | 🇺🇸 USA |
 Accenture ACN | ₹5.874 T | 1,320.36% | 🇮🇪 Ireland |